Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

     
(X)   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

    For the quarterly period ended July 3, 2004

OR

     
(   )   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

    For the transition period from ______________ to _______________

Commission File Number 0-15386

CERNER CORPORATION


(Exact name of registrant as specified in its charter)
     
Delaware   43-1196944

 
 
 
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification Number)

2800 Rockcreek Parkway
North Kansas City, Missouri 64117
(816) 201-1024


(Address of Principal Executive Offices, including zip code;
registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) with the Commission, and (2) has been subject to such filing requirements for the past 90 days.

Yes (X)       No (   )

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes (X)       No (   )

     There were 36,092,714 shares of Common Stock, $.01 par value, outstanding at July 3, 2004.

 


CERNER CORPORATION AND SUBSIDIARIES

INDEX

             
  Financial Information:        
  Financial Statements:        
 
  Condensed Consolidated Balance Sheets as of July 3, 2004 (unaudited) and January 3, 2004     1  
 
  Condensed Consolidated Statements of Earnings for the three and six months ended July 3, 2004 and June 28, 2003 (unaudited)     2  
 
  Condensed Consolidated Statements of Cash Flows for the six months ended July 3, 2004 and June 28, 2003 (unaudited)     3  
 
  Notes to Condensed Consolidated Financial Statements (unaudited)     4  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     10  
  Quantitative and Qualitative Disclosures About Market Risk     22  
  Controls and Procedures     22  
  Other Information:     22  
  Legal Proceedings     22  
  Exhibits and Reports on Form 8-K     24  
 Certification
 Certification
 Certification
 Certification

 


Table of Contents

Part I. Financial Information

Item 1. Financial Statements

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
                 
    July 3,   January 3,
    2004
  2004
(In thousands)   (unaudited)        
Assets
               
Current Assets:
               
Cash and cash equivalents
  $ 137,224     $ 121,839  
Receivables
    258,744       256,574  
Inventory
    10,473       12,434  
Prepaid expenses and other
    35,212       38,132  
 
   
 
     
 
 
Total current assets
    441,653       428,979  
Property and equipment, net
    217,655       204,953  
Software development costs, net
    150,242       141,090  
Goodwill, net
    52,831       51,573  
Intangible assets, net
    22,189       24,036  
Investments
    410       692  
Other assets
    6,662       8,017  
 
   
 
     
 
 
 
  $ 891,642     $ 859,340  
 
   
 
     
 
 
Liabilities and Stockholders’ Equity
               
Current Liabilities:
               
Accounts payable
  $ 20,198     $ 20,753  
Current installments of long-term debt
    24,715       21,162  
Deferred revenue
    62,614       64,879  
Deferred income taxes
    15,521       15,586  
Accrued payroll and tax withholdings
    45,811       45,004  
Other accrued expenses
    12,281       10,095  
 
   
 
     
 
 
Total current liabilities
    181,140       177,479  
Long-term debt
    111,095       124,570  
Deferred income taxes
    62,852       59,500  
Deferred revenue
    1,551       1,945  
Minority owners’ equity interest in subsidiary
    1,166       1,166  
Stockholders’ Equity:
               
Common stock, $.01 par value, 150,000,000 shares authorized, 37,595,713 shares issued at July 3, 2004 and 37,057,364 issued in 2003
    376       371  
Additional paid-in capital
    248,387       236,969  
Retained earnings
    307,806       279,363  
Treasury stock, at cost (1,502,999 shares in 2004 and 2003)
    (26,793 )     (26,793 )
Accumulated other comprehensive income:
               
Foreign currency translation adjustment
    4,062       4,770  
 
   
 
     
 
 
Total stockholders’ equity
    533,838       494,680  
 
   
 
     
 
 
 
  $ 891,642     $ 859,340  
 
   
 
     
 
 

See notes to condensed consolidated financial statements.

1


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(UNAUDITED)
                                 
    Three Months Ended
  Six Months Ended
    July 3,   June 28,   July 3,   June 28,
(In thousands, except per share data)   2004
  2003
  2004
  2003
Revenues:
                               
System sales
  $ 84,853     $ 82,742     $ 169,365     $ 161,336  
Support, maintenance and services
    133,949       116,240       261,018       229,172  
Reimbursed travel
    9,588       8,713       16,734       15,378  
 
   
 
     
 
     
 
     
 
 
Total revenues
    228,390       207,695       447,117       405,886  
 
   
 
     
 
     
 
     
 
 
Costs and expenses:
                               
Cost of revenues
    50,564       53,096       97,237       101,348  
Sales and client service
    94,232       86,646       187,074       174,737  
Software development
    42,769       38,457       85,323       75,915  
General and administrative
    14,919       13,149       29,064       26,291  
 
   
 
     
 
     
 
     
 
 
Total costs and expenses
    202,484       191,348       398,698       378,291  
 
   
 
     
 
     
 
     
 
 
Operating earnings
    25,906       16,347       48,419       27,595  
Other income (expense):
                               
Interest expense, net
    (1,792 )     (1,603 )     (3,907 )     (3,449 )
Other income
    (174 )     127       2,840       143  
 
   
 
     
 
     
 
     
 
 
Total other, net
    (1,966 )     (1,476 )     (1,067 )     (3,306 )
 
   
 
     
 
     
 
     
 
 
Earnings before income taxes
    23,940       14,871       47,352       24,289  
Income taxes
    (9,626 )     (5,928 )     (18,909 )     (9,753 )
 
   
 
     
 
     
 
     
 
 
Net earnings
    14,314       8,943       28,443       14,536  
 
   
 
     
 
     
 
     
 
 
Basic earnings per share
  $ .40     $ .25     $ .79     $ .41  
Basic weighted average shares outstanding
    36,044       35,395       35,799       35,476  
Diluted earnings per share
  $ .38       .25       .76       .40  
Diluted weighted average shares outstanding
    37,510       35,731       37,306       36,215  

See notes to condensed consolidated financial statements.

2


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
                 
    Six Months Ended
(In thousands)   July 3, 2004
  June 28, 2003
Cash flows from operating activities:
               
Net earnings
  $ 28,443     $ 14,536  
Adjustments to reconcile net earnings to net cash provided by operating activities:
               
Depreciation and amortization
    42,963       32,966  
Gain on sale of business
    (3,023 )      
Non-employee stock option compensation expense
          23  
Provision for deferred income taxes
    3,347       4,215  
Changes in assets and liabilities, net of business sold:
               
Receivables, net
    (3,028 )     17,033  
Inventory
    823       490  
Prepaid expenses and other
    (10,732 )     (1,759 )
Accounts payable
    (123 )     (13,853 )
Accrued income taxes
    8,952       851  
Deferred revenue
    (1,811 )     9,568  
Other accrued liabilities
    1,595       (5,535 )
 
   
 
     
 
 
Total adjustments
    38,963       43,999  
 
   
 
     
 
 
Net cash provided by operating activities
    67,406       58,535  
 
   
 
     
 
 
Cash flows from investing activities:
               
Purchase of capital equipment
    (17,738 )     (11,344 )
Purchase of land, buildings and improvements
    (9,191 )     (22,586 )
Acquisition of business, net of cash acquired
    (238 )      
Proceeds from the sale of business
    12,000        
Repayment of notes receivable
    1,943       215  
Capitalized software development costs
    (30,381 )     (28,749 )
 
   
 
     
 
 
Net cash used in investing activities
    (43,605 )     (62,464 )
 
   
 
     
 
 
Cash flows from financing activities:
               
Repayment of long-term debt
    (19,528 )     (14,015 )
Purchase of treasury stock
          (5,930 )
Proceeds from exercise of options
    11,775       1,347  
Associate stock purchase plan discounts
    (352 )     (248 )
 
   
 
     
 
 
Net cash used in financing activities
    (8,105 )     (18,846 )
 
   
 
     
 
 
Effect of exchange rate changes on cash
    (311 )     1,270  
 
   
 
     
 
 
Net increase (decrease) in cash and cash equivalents
    15,385       (21,505 )
Cash and cash equivalents at beginning of period
    121,839       142,543  
 
   
 
     
 
 
Cash and cash equivalents at end of period
  $ 137,224     $ 121,038  
 
   
 
     
 
 
Supplemental disclosures of cash flow information:
               
Noncash financing activities
               
Issuance of note payable for unused software credits
  $ 7,500        
Acquisition of equipment through capital leases
  $ 3,323        

See notes to condensed consolidated financial statements.

3


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(1) Interim Statement Presentation & Accounting Policies

The condensed consolidated financial statements included herein have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s latest annual report on Form 10-K.

In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments (consisting of only normal recurring accruals) necessary to present fairly the financial position, and the results of operations and cash flows for the periods presented. The results for the three and six-month periods are not necessarily indicative of the operating results for the entire year.

Statement of Financial Accounting Standards No. 130, “Reporting Comprehensive Income,” establishes requirements for reporting and display of comprehensive income and its components. Total Comprehensive Income, which includes net earnings and foreign currency translation adjustments amounted to $13,707,000 and $12,038,000 for the three months July 3, 2004 and June 28, 2003 and $27,735,000 and $17,169,000 for the six months ended July 3, 2004 and June 28, 2003, respectively.

The terms of the Company’s software license agreements with its clients generally provide for a limited indemnification of such intellectual property against losses, expenses and liabilities arising from third-party claims based on alleged infringement by the Company’s solutions of an intellectual property right of such third party. The terms of such indemnification often limit the scope of and remedies for such indemnification obligations and generally include a right to replace or modify an infringing solution. To date, the Company has not had to reimburse any of its clients for any losses related to these indemnification provisions pertaining to third-party intellectual property infringement claims. For several reasons, including the lack of prior indemnification claims and the lack of a monetary liability limit for certain infringement cases under the terms of the corresponding agreements with its clients, the Company cannot determine the maximum amount of potential future payments, if any, related to such indemnification provisions.

On September 27, 2003, the Company adopted Financial Accounting Standards Board Interpretation No. 46 (“FIN 46”), “Consolidation of Variable Interest Entities an Interpretation of APB No. 51.” The Interpretation provides guidance on the identification of entities for which control is achieved through means other than through voting rights (“variable interest entities’” or “VIEs”) and how to determine when and which business enterprises should consolidate the VIE (the “primary beneficiary”). In addition, FIN 46 requires that both the primary beneficiary and all other enterprises with a significant variable interest in a VIE make additional disclosures.

The Company began consolidating the operations of Cerner Arabia Ltd (“Cerner Arabia”) in September 2003. Cerner Arabia is a software company located in Riyadh, Saudi Arabia. Revenues are derived primarily from the sale of clinical, financial and administrative information systems and solutions. The consolidation of Cerner Arabia resulted in an increase to revenues of $497,000 and $814,000 and an increase in net earnings of $191,000 and $127,000 for the three and six months ended July 3, 2004, respectively.

(2) Earnings Per Share

Basic earnings per share (EPS) excludes dilution and is computed by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company. A reconciliation of the numerators and denominators of the basic and diluted per-share computations is as follows:

4


Table of Contents

                                                 
    Three months ended   Three months ended
    July 3, 2004
  June 28, 2003
    Earnings   Shares   Per-Share   Earnings   Shares   Per-Share
(In thousands, except per share data)   (Numerator)
  (Denominator)
  Amount
  (Numerator)
  (Denominator)
  Amount
Basic earnings per share
                                               
Income available to common stockholders
  $ 14,314       36,044     $ .40     $ 8,943       35,395     $ .25  
Effect of dilutive securities
                                               
Stock options
          1,466                     336          
Diluted earnings per share
                                               
 
   
 
     
 
     
 
     
 
     
 
     
 
 
Income available to common stockholders including
Assumed conversions
  $ 14,314       37,510     $ .38     $ 8,943       35,731     $ .25  
 
   
 
     
 
     
 
     
 
     
 
     
 
 

     Options to purchase 2,190,000 and 5,489,000 shares of common stock at per share prices ranging from $43.14 to $273.72 and $21.50 to $574.82 were outstanding at the three-months ended July 3, 2004 and June 28, 2003, respectively, but were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares during the period.

                                                 
    Six months ended   Six months ended
    July 3, 2004
  June 28, 2003
    Earnings   Shares   Per-Share   Earnings   Shares   Per-Share
(In thousands, except per share data)   (Numerator)
  (Denominator)
  Amount
  (Numerator)
  (Denominator)
  Amount
Basic earnings per share
                                               
Income available to common stockholders
  $ 28,443       35,799     $ .79     $ 14,536       35,476     $ .41  
Effect of dilutive securities
                                               
Stock options
          1,507                     739          
Diluted earnings per share
                                               
 
   
 
     
 
     
 
     
 
     
 
     
 
 
Income available to common stockholders including
Assumed conversions
  $ 28,443       37,306     $ .76     $ 14,536       36,215     $ .40  
 
   
 
     
 
     
 
     
 
     
 
     
 
 

Options to purchase 1,650,000 and 3,898,000 shares of common stock at per share prices ranging from $43.77 to $273.72 and $27.92 to $574.82 were outstanding at the six-months ended July 3, 2004 and June 28, 2003, respectively, but were not included in the computation of diluted earnings per share because the options’ exercise price was greater than the average market price of the common shares during the period.

(3) Accounting for Stock Options

The Company applies the intrinsic-value-based method of accounting prescribed by Accounting Principles Board (APB) Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations including FASB Interpretation No. 44, “Accounting for Certain Transactions involving Stock Compensation, an interpretation of APB Opinion No. 25,” issued in March 2000, to account for its fixed–plan stock options. Under this method, compensation expense is recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price. Statement of Financial Accounting Standards No. 123, “Accounting for Stock-Based Compensation,” established accounting and disclosure requirements using a fair-value-based method of accounting for stock-based employee compensation plans. As allowed by SFAS No. 123, the Company has elected to continue to apply the intrinsic-value-based method of accounting described above, and has adopted only the disclosure requirements of SFAS No. 123. The following is a reconciliation of reported net earnings to adjusted net earnings had the

5


Table of Contents

Company recorded compensation expense based on the fair value at the grant date for its stock options under SFAS 123 for the three and six months ended July 3, 2004 and June 28, 2003.

                                 
    Three months ended
  Six months ended
(In thousands, except per share data)   July 3,
2004

  June 28,
2003

  July 3,
2004

  June 28,
2003

Reported net earnings
  $ 14,314       8,943       28,443       14,536  
Less: stock-based compensation expense determined under fair-value-based method for all awards
    (1,020 )     (2,871 )     (2,924 )     (6,376 )
 
   
 
     
 
     
 
     
 
 
Pro-forma net earnings
    13,294       6,072       25,519       8,160  
 
   
 
     
 
     
 
     
 
 
Basic earnings per share:
                               
Reported net earnings
  $ .40       .25       .79       .41  
Less: stock-based compensation expense determined under fair-value-based method for all awards, net of tax
    (.03 )     (.08 )     (.08 )     (.18 )
 
   
 
     
 
     
 
     
 
 
Pro-forma net earnings
    .37       .17       .71       .23  
 
   
 
     
 
     
 
     
 
 
Diluted earnings per share:
                               
Reported net earnings
  $ .38       .25       .76       .40  
Less: stock-based compensation expense determined under fair-value-based method for all awards
    (.03 )     (.08 )     (.08 )     (.18 )
 
   
 
     
 
     
 
     
 
 
Pro-forma net earnings
    .35       .17       .68       .22  
 
   
 
     
 
     
 
     
 
 

Pro forma net earnings reflect only options granted since January 1, 1995. Therefore, the full impact of calculating compensation expense for stock options under FAS 123 is not reflected in the adjusted net earnings amounts presented above, because compensation cost is reflected over the options’ vesting period of ten years for these options. Compensation expense for options granted prior to January 1, 1995 is not considered.

(4) Business Divestiture

On March 15, 2004 the Company sold the referential content portion of Zynx Health Incorporated (Zynx) for $12 million. The Company retained the life sciences portion of the business, which is engaged in selling life sciences data to pharmaceutical companies for use in research, and the Company retained rights to use the Zynx content in its solutions going forward. The sale of Zynx resulted in a gain of $1,826,000, net of $1,197,000 of tax.

6


Table of Contents

(5) Receivables

Receivables consist of accounts receivable and contracts receivable. Accounts receivable represent recorded revenues that have been billed. Contracts receivable represent recorded revenues that are billable by the Company at future dates under the terms of a contract with a client. Billings and other consideration received on contracts in excess of related revenues recognized under the percentage-of –completion method are recorded as deferred revenue. A summary of receivables is as follows:

                 
    July 3,   January 3,
(In thousands)   2004
  2004
Accounts receivable
  $ 169,939       162,234  
Contracts receivable
    88,805       94,340  
 
   
 
     
 
 
Total receivables
  $ 258,744       256,574  
 
   
 
     
 
 

The Company provides an allowance for estimated uncollectible accounts based upon historical experience and management’s judgment. At July 3, 2004 and January 3, 2004 the allowance for estimated uncollectible accounts was $14,190,000 and $12,056,000, respectively.

(6) Goodwill and Other Intangible Assets

Goodwill and intangible assets with indefinite lives are evaluated for impairment annually or whenever there is an impairment indicator. All goodwill is assigned to a reporting unit, where it is subject to an impairment test based on fair value. The Company’s 2004 review of goodwill was completed in the second quarter of 2004 and indicated that goodwill was not impaired.

The Company’s intangible assets, other than goodwill or intangible assets with indefinite lives, are all subject to amortization and are summarized as follows:

                                         
                 
    Weighted Average   July 3, 2004
  January 3, 2004
    Amortization Period   Gross Carrying   Accumulated   Gross Carrying   Accumulated
(In thousands)   (Yrs)
  Amount
  Amortization
  Amount
  Amortization
Purchased software
    5.0     $ 36,953       17,071       36,236       14,683  
Customer lists
    7.0       3,700       1,975       3,700       1,711  
Patents
    14.0       635       97       552       86  
Non-compete agreements
    7.0       75       31       50       22  
 
   
 
     
 
     
 
     
 
     
 
 
Total
    5.32     $ 41,363       19,174       40,538       16,502  
 
           
 
     
 
     
 
     
 
 

Aggregate amortization expense for the six months ended July 3, 2004 and June 28, 2003 was $2,672,000 and $3,111,000 respectively. Estimated aggregate amortization expense for each of the next five years is as follows:

                 
For the remaining six months:
    2004     $ 3,636  
For year ended:
    2005       6,898  
 
    2006       5,633  
 
    2007       3,729  
 
    2008       1,687  

7


Table of Contents

The changes in the carrying amount of goodwill for the six months ended July 3, 2004 are as follows:

         
Balance as of January 3, 2004
  $ 51,573  
Goodwill acquired during the six months ended July 3, 2004
    8,122  
Goodwill divested during the six months ended July 3, 2004
    (6,513 )
Foreign currency translation adjustment at July 3, 2004
    (351 )
 
   
 
 
Balance as of July 3, 2004
  $ 52,831  
 
   
 
 

(7) Contingencies

As previously disclosed, the Company received notice in April 2003 that three shareholder class action lawsuits were filed against it and five of its officers in the United States District Court for the Western District of Missouri. Subsequently, five additional shareholder class action lawsuits were filed against the Company. All of these lawsuits were filed after a decline in the Company’s stock price following the Company’s announcement on April 3, 2003 that the Company would not meet revenue and earnings estimates for the first quarter of 2003.

On August 20, 2003, the Court ordered that all of the lawsuits be consolidated under Case No. 03-CV-00296-DW and appointed Phil Crabtree as Lead Plaintiff. On December 1, 2003, the Lead Plaintiff filed a Consolidated Class Action Complaint. In general, the consolidated complaint alleges that, during a class period commencing as of July 17, 2002 and ending April 2, 2003, the Company and individual named defendants misrepresented or failed to disclose certain factors, which they allege impacted the Company’s business and anticipated revenue and earnings, all allegedly in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The Company believes that all the claims asserted in the Consolidated Amended Complaint are without merit and intends to vigorously defend those claims.

On June 16, 2004 the Court granted the Company’s and the individual defendants’ Motion To Dismiss and ordered the Consolidated Class Action Complaint dismissed with prejudice against re-filing. On June 30, 2004, the Lead Plaintiff filed a Notice of Appeal seeking review of the District Court’s decision by the United States Court of Appeals for the Eighth Circuit. The Company does not know when the Court of Appeals will rule on the Lead Plaintiff’s appeal.

(8) Segment Reporting

Statement of Financial Accounting Standards No. 131, “Disclosures about Segments of an Enterprise and Related Information” establishes annual and interim reporting standards for operating segments of a company. It also requires entity-wide disclosures about the products and services an entity provides, the material countries in which it holds assets and reports revenues, and its major clients. In 2003, the Company organized geographically. The Company’s six geographic business segments are: Great Lakes, Mid-America, North Atlantic, Southeast, West and Global.

Revenues are derived primarily from the sale of clinical, financial and administrative information systems and solutions. The cost of revenues includes the cost of third party consulting services, computer hardware and sublicensed software purchased from computer and software manufacturers for delivery to clients. It also includes the cost of hardware maintenance and sublicensed software support subcontracted to the manufacturers. Operating expenses incurred by the geographic business segments consist of sales and client service expenses including salaries of sales and client service personnel, communications expenses and unreimbursed travel expenses. Performance of the segments is assessed at the operating earnings level and, therefore, the segment operations have been presented as such. “Other” includes revenues not generated by the operating segments and expenses such as software development, marketing, general and administrative and depreciation that have not been allocated to the operating segments. The Company does not track assets by geographical business segment.

Accounting policies for each of the reportable segments are the same as those used on a consolidated basis. The following table presents a summary of the operating information for the three and six-months ended July 3, 2004 and June 28, 2003:

8


Table of Contents

                                                                 
    Operating Segments
       
Three months ended   Great   Mid-   North   South-                
July 3, 2004   Lakes
  America
  Atlantic
  east
  West
  Global